Insulin-like growth factor binding protein-3 (IGFBP-3): a biomarker of coronary artery disease induced myocardial ischaemia
Authors:
Open Access
- 10 March 2025
- journal article
- Published by Oxford University Press (OUP) in European Heart Journal Open
- Vol. 5 (2) , oeaf028
Abstract
Aims: Among individuals presenting to the emergency department (ED) with chest pain, clinical uncertainty surrounds the appropriate identification of non-myocardial infarction (MI) individuals who would most benefit from objective functional/anatomical testing (e.g. imaging). We applied a proteomic biomarker discovery approach to identify novel candidates reflecting coronary artery disease (CAD) induced ischaemia that could translate to measurement in clinical samples. Methods and results: Mass spectroscopy (MS) of perfusate from an isolated rat heart model of cardiac ischaemia identified >100 novel protein biomarkers. A prominent candidate, insulin-like growth factor binding protein (IGFBP-3), was then interrogated for its ability to identify CAD-related ischaemia (e.g. positive cardiac stress test; unstable angina pectoris, UAP; arterial stenosis >70% on angiography) in multiple patient sample sets [cardiac stress testing, n = 12; septal alcohol ablation (SAA), n = 12; ED chest pain, n = 2977]. In cardiac stress testing, a significant delta IGFBP-3 (ΔIGFBP-3) between 0 and 150 min was seen in positive, but not negative, tests (P = 0.03). In SAA, peripheral IGFBP-3 levels did not change over 24 h (P = 0.57). In ED patients, ΔIGFBP-3 between 0 and 2 h (i) identified more 365-day low-risk major adverse cardiac event cases (27–30%), (ii) provided 7% improvement in positive predictive value over a clinical model for the identification of unstable angina (P = 0.01), and (iii) was a significant, independent predictor of >70% stenosis on angiography, improving indeterminate risk prediction by 9% (95% CI 3–15%). Conclusion: Our discovery approach has translated IGFBP-3 as a potential biomarker to identify significant CAD/ischaemia in patients who do not meet diagnostic thresholds for MI.Keywords
Funding Information
- Health Research Council of New Zealand
- Canterbury Medical Research Foundation
- National Heart Foundation of New Zealand
- Swiss National Science Foundation
- Swiss Heart Foundation
- University Hospital Basel
- University of Basel
- Upstream Medical Technologies
This publication has 42 references indexed in Scilit:
- Association of Total Insulin-Like Growth Factor-I, Insulin-Like Growth Factor Binding Protein-1 (IGFBP-1), and IGFBP-3 Levels with Incident Coronary Events and Ischemic StrokeThe Journal of Clinical Endocrinology & Metabolism, 2007
- Proteome Analysis of Isolated Perfused Organ Effluent as a Novel Model for Protein Biomarker DiscoveryJournal of Proteome Research, 2005
- IGF-I and IGFBP-3 transport in the rat heartAmerican Journal of Physiology-Endocrinology and Metabolism, 2003
- IGFBP-3 binding to endothelial cells inhibits plasmin and thrombin proteolysisAmerican Journal of Physiology-Endocrinology and Metabolism, 2002
- Neonatal and adult human heart tissues from normal subjects and patients with ischemic, dilated or hypertrophic cardiomyopathy express insulin-like growth factor binding protein-3 (IGFBP-3)Journal of Endocrinological Investigation, 2000
- Coordinate expression of the insulin-like growth factor system after microembolisation in porcine heartCardiovascular Research, 1997
- Expression of IGF-I, IGF-I receptor and IGF binding proteins -1, -2, -3, -4 and -5 in human atherectomy specimensRegulatory Peptides, 1996
- Rapid clearance of human insulin-like growth factor binding protein-3 from the rat circulation and cellular localization in liver, kidney and stomach.1996
- Synthesis of insulin-like growth factor binding proteins and of the acid-labile subunit of the insulin-like growth factor ternary binding protein complex in primary cultures of human hepatocytesJournal of Hepatology, 1995
- Cellular localization and regulation of gene expression for components of the insulin-like growth factor ternary binding protein complex.Endocrinology, 1994